Vivimed Labs Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Santosh Varalwar
Chief executive officer
₹12.0m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 33.9yrs |
| CEO ownership | 1.6% |
| Management average tenure | 4.6yrs |
| Board average tenure | 22.3yrs |
Recent management updates
Recent updates
Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?
Mar 30
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Dec 14Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Jun 30Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Feb 22Did Vivimed Labs Limited (NSE:VIVIMEDLAB) Insiders Buy Up More Shares?
Jan 19Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Nov 25
Are Insiders Buying Vivimed Labs Limited (NSE:VIVIMEDLAB) Stock?
Sep 22Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?
Jul 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -₹3b |
| Mar 31 2023 | ₹12m | ₹12m | -₹3b |
| Dec 31 2022 | n/a | n/a | -₹809m |
| Sep 30 2022 | n/a | n/a | -₹862m |
| Jun 30 2022 | n/a | n/a | -₹875m |
| Mar 31 2022 | ₹12m | ₹12m | -₹676m |
| Dec 31 2021 | n/a | n/a | -₹768m |
| Sep 30 2021 | n/a | n/a | -₹1b |
| Jun 30 2021 | n/a | n/a | -₹930m |
| Mar 31 2021 | ₹10m | ₹10m | -₹719m |
| Dec 31 2020 | n/a | n/a | -₹1b |
| Sep 30 2020 | n/a | n/a | -₹937m |
| Jun 30 2020 | n/a | n/a | -₹1b |
| Mar 31 2020 | ₹6m | ₹6m | -₹1b |
| Dec 31 2019 | n/a | n/a | -₹485m |
| Sep 30 2019 | n/a | n/a | -₹56m |
| Jun 30 2019 | n/a | n/a | ₹391m |
| Mar 31 2019 | ₹6m | ₹6m | ₹574m |
| Dec 31 2018 | n/a | n/a | ₹686m |
| Sep 30 2018 | n/a | n/a | ₹787m |
| Jun 30 2018 | n/a | n/a | ₹825m |
| Mar 31 2018 | ₹6m | ₹6m | ₹779m |
| Dec 31 2017 | n/a | n/a | ₹2b |
| Sep 30 2017 | n/a | n/a | ₹2b |
| Jun 30 2017 | n/a | n/a | ₹2b |
| Mar 31 2017 | ₹6m | ₹6m | ₹2b |
Compensation vs Market: Santosh's total compensation ($USD143.97K) is above average for companies of similar size in the Indian market ($USD39.22K).
Compensation vs Earnings: Santosh's compensation has been consistent with company performance over the past year.
CEO
Santosh Varalwar (61 yo)
33.9yrs
Tenure
₹12,000,000
Compensation
Mr. Santosh Varalwar has been the Managing Director of Vivimed Labs Limited since January 27, 2004 and has been its Executive Director since November 09, 1989. Mr. Varalwar served as Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | no data | ₹12.00m | 1.57% ₹ 6.4m | |
| Chief Financial Officer | 1.5yrs | ₹6.00m | no data | |
| Compliance Officer & Company Secretary | no data | ₹3.06m | no data | |
| Whole Time Director | 4.6yrs | ₹3.00m | 1.25% ₹ 5.1m | |
| Executive Director | no data | ₹10.00m | 2.26% ₹ 9.3m | |
| Chief Executive of Uquifa - Vivimed’s API Division | 33.8yrs | no data | no data |
4.6yrs
Average Tenure
61yo
Average Age
Experienced Management: VIVIMEDLAB's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 33.9yrs | ₹12.00m | 1.57% ₹ 6.4m | |
| Whole Time Director | 28.9yrs | ₹3.00m | 1.25% ₹ 5.1m | |
| Executive Director | 15.8yrs | ₹10.00m | 2.26% ₹ 9.3m | |
| Non-Executive Promoter Director | 33.9yrs | ₹175.00k | 1.95% ₹ 8.0m | |
| Independent Chairman & Lead Independent Director | 3.7yrs | ₹375.00k | no data | |
| Non-Executive Independent Woman Director | 1.7yrs | ₹375.00k | no data |
22.3yrs
Average Tenure
68yo
Average Age
Experienced Board: VIVIMEDLAB's board of directors are seasoned and experienced ( 22.3 years average tenure).